
Sign up to save your podcasts
Or


PharmEasy co-founder Siddharth Shah outlines the entrepreneurial journey of the five young co-founders behind this online pharmacy company, and why they “never say never”. As co-founder & Chief Executive of API Holdings (parent company of PharmEasy), Siddharth speaks to Business Line on working with industry veterans like Aditya Puri and Dr Velumani, both representing different generations and economies. API recently formalised a deal to buy over 66 percent in diagnostics laboratory network Thyrocare, for Rs 4,546 crore, a first-time where a listed company is bought by a unicorn. Part of a plan or serendipity? Siddharth gives us the inside track.
By BusinessLinePharmEasy co-founder Siddharth Shah outlines the entrepreneurial journey of the five young co-founders behind this online pharmacy company, and why they “never say never”. As co-founder & Chief Executive of API Holdings (parent company of PharmEasy), Siddharth speaks to Business Line on working with industry veterans like Aditya Puri and Dr Velumani, both representing different generations and economies. API recently formalised a deal to buy over 66 percent in diagnostics laboratory network Thyrocare, for Rs 4,546 crore, a first-time where a listed company is bought by a unicorn. Part of a plan or serendipity? Siddharth gives us the inside track.

4,225 Listeners

1,713 Listeners

296 Listeners

1,649 Listeners

14 Listeners

57 Listeners

684 Listeners

2,592 Listeners

1,089 Listeners

89 Listeners

40 Listeners

5 Listeners

15 Listeners

11 Listeners

10 Listeners